Keyword: AMAG Pharmaceuticals
AMAG's female libido drug Vyleesi has just won FDA approval. But will it reach blockbuster state? Management and analysts have different opinions.
When looking for consumer marketing lessons that can translate to pharma, Amag Pharmaceutical needed to look no further than its own operations.
Industry lobbying group PhRMA has cleared its decks of nearly two dozen members as it tries to distance itself from those companies most likely to catch heat over drug pricing practices.
AMAG Pharmaceuticals has big ambitions for its women’s health business, so it’s snapped up the rights to a new med, Intrarosa, to beef up that portfolio. And it’s bringing on 150 new reps to detail the med.
Drugmaker AMAG Pharmaceuticals said it reached key development milestones for two of its pipeline drugs: the subcutaneous autoinjector version of Makena and the anemia drug Feraheme.